Notably, using spatial proteomics, a very recent study by Rius Rigau et al. [15] confirmed the presence of a CD34+/α-SMA+/CD31+ EC subpopulation that was increased in the skin of SSc patients and expressed high levels of different transcription factors known to promote EndoMT. This evidence concerns the gene PECAM1 and systemic sclerosis.